Synergistic cytotoxic interactions between sodium butyrate, MG132 and camptothecin in human retinoblastoma Y79 cells

Tumor Biology

Volumn 21, Issue 6, 2000, Pages 337-348

  Lauricella, Marianna ^b   Calvaruso, Giuseppe ^b   Giuliano, Michela ^b   Carabillò, Maria ^b   Emanuele, Sonia ^b   Vento, Renza ^b   Tesoriere, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE

Author keywords

Apoptosis; Proteasome inhibitors; Retinoblastoma; Sodium butyrate; Topoisomerase inhibitors

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BUTYRIC ACID; CAMPTOTHECIN; CASPASE 3; DNA TOPOISOMERASE INHIBITOR; LAMIN B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEASOME INHIBITOR; PROTEIN BCL 2; PROTEIN P53; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CELL VIABILITY; CYTOTOXICITY; DRUG POTENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETINOBLASTOMA; SIGNAL TRANSDUCTION;

EID: 0033802887     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030139     Document Type: Article

References (35)

1. Benedict WF, Murphree AL, Banerjee A, Spina CA, Sparkes MC, Sparkers RS: Patient with 13 chromosome deletion evidence that the retinoblastoma gene is a recessive cancer gene. Science 1983;219:973-975.
2. Abramson DH, Ellsworth RM, Kitchin D, Tung G: Second nonocular tumors in retinoblastoma survivors. Opthalmology 1984;91:1351-1355.
3. Hensel CH, Hsieh CL, Gazdar AF, Johnson BE, Sakaguchi AY, Naylor SL, Lee W-H, Lee Y-HP: Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res 1990;50:3067-3072.
4. Beijersbergen RL, Bernards R: Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim Biophys Acta 1996; 1287:103-120.
5. Herwig S, Strauss M: The retinoblastoma protein: A master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem 1997;246: 581-601.
6. Mongebesser SD, Williams BO, Jacks T, De Pinho RA: p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994:371:72-74.
7. Chabner BA, Myers CE: Clinical pharmacology of cancer chemotherapy; in De Vita VTJ, Hellman J, Rosenberg SA (eds): Cancer: Principles and Practice at Oncology. Philadelphia, Lippincott, 1989, pp 349-395.
8. Lee EY, Bookstein R, Young LJ, Lin CJ, Rosenfeld MG, Lee WH: Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79. Proc Natl Acad Sci USA 1988;85:6017-6021.
9. Giuliano M, Lauricella M, Vassallo E, Carabillò M, Vento R, Tesoriere G: Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors. Invest Ophthalmol Vis Sci 1998;39:1300-1311.
10. Lauricella M, Giuliano M, Emanuele S, Vento R, Tesoriere G: Apoptotic effects of different drugs on cultured retinoblastoma Y79 cells. Tumor Biol 1998;19:356-363.
11. Giuliano M, Lauricella M, Calvaruso G, Carabillò M, Emanuele S, Vento R, Tesoriere G: The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells. Cancer Res 1999;59:5586-5595.
12. Vento R, D'Alessandro N, Giuliano M, Lauricella M, Carabillò M, Tesoriere G: Induction of apoptosis by arachidonic acid in human retinoblastoma Y79 cells: Involvement of oxidative stress. Exp Eye Res, in press.
13. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application and cytotoxicity assay. J Immunol Methods 1983;65:55-63.
14. Chou TC, Talalay P: Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Eur J Biochem 1981;115:207-216.
15. El-Deiry WS, Wade Harper J, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, et al: WAF-1/Cip1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;76:1013-1023.
16. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge S: The p21 cdk-interacting cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-816.
17. O'Connor R, Kauffmann-Zeh A, Liu Y, Lehar S, Evan GI, Baserga R, Blattler WA: Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol Cell Biol 1997;17:427-435.
18. Adams JM, Cory S: The Bcl-2 protein family: Arbiters of cell survival. Science 1998;281:1322-1326.
19. Chen X, Ko LI, Jayaraman L, Prives C: p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 1996;10: 2438-2451.
20. Nevins JR: E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992;258: 424-429.
21. Macleod K: pRb and E2F-1 in mouse development and tumorigenesis. Curr Opin Genet Dev 1999;9: 31-39.
22. Hsieh J-K, Fredersdorf S, Kouzarides T, Martin K, Lu X: E2F1-induced apoptosis required DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev 1997;11:1840-1852.
23. Navarro JM, Olmo N, Turnay J, Lopez-Conejo MT, Lizarbe MA: Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: Increase in 5′-nucleotidase activity. Eur J Clin Invest 1997;27: 620-628.
24. Barnard JA, Warwick G: Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ 1993;4:495-501.
25. Conway RM, Madigan MC, Penfold PL, Billson FA: Induction of apoptosis by sodium butyrate in the human Y-79 retinoblastoma cell line. Oncol Res 1995;7:289-297.
26. McBain JA, Eastman A, Nobel CS, Mueller GC: Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem Pharmacol 1997;53:1357-1368.
27. Kalderon D: Protein degradation: De-ubiquitinate to decide your fate. Curr Biol 1996;6:662-665.
28. Mercurio F, Manning AM: Multiple signals converging on NF-kappaB. Curr Opin Cell Biol 1999;11:226-232.
29. Hilt W, Wolf DH: Proteasomes: Destruction as a programme. Trends Biochem Sci 1996;21:96-101.
30. Bush KT, Goldberg AL, Nigam S: Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J Biol Chem 1997;272:9086-9092.
31. Fujita E, Mukasa T, Tsukahara T, Arahata K, Omura S, Momoi T: Enhancement of CPP32-like activity in the TNF-treated U937 cells by the proteasome inhibitors. Biochem Biophys Res Commun 1996;224: 74-79.
32. Lee DH, Goldberg AL: Proteasome inhibitors: Valuable new tools for cell biologists. Trends Cell Biol 1998;8:397-403.
33. Meriin AB, Gabai VL, Yaglom J, Shifrin VI, Sherman MY: Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis. J Biol Chem 1998;273:6373-6379.
34. Coradini D, Biffi A, Costa A, Pellizzaro C, Pirronello E, Di Fronzo G: Effect of sodium butyrate on human breast cancer cell lines. Cell Prolif 1997;30:149-159.
35. Garcia-Bermejo L, Vilaboa NE, Perz C, Galan A, De Blas E, Aller P: Modulation of heat-shock protein 70 (HSP70) gene expression by sodium butyrate in U-937 promonocytic cells: Relationships with differentiation and apoptosis. Exp Cell Res 1997;236:268-274.